The safety results of ACASA-TAVI and NOTION-4 were discordant as well, Windecker said. “But please note that overall event numbers were very low, the treatment estimates are imprecise, and the ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

The lack of impact on outcomes was surprising, says the investigator, though the FAST-CTCA trial may still come through.

An intervention in rural China continued to impact hypertension, CV events, and dementia risk 4 years after it ended.

SWITCH-SWEDEHEART’s unique design randomized healthcare regions but wasn’t a head-to-head comparison with ticagrelor.

As the first TTVR trial to impact HF hospitalization and mortality, it “feels like a COAPT-like moment,” says Mohamad ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

While there was no change in disability-free survival, the results should impact guidelines, says François Mach.

The study supports a strategy of going wire-free for functional assessment in this setting and may well be “practice changing ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Carlos Collet speaks with Simone Biscaglia about upcoming presentations in Munich, including the AIR-STEMI trial findings.